励晶太平洋(00575.HK)终止收购Yooya之讨论
励晶太平洋(00575.HK)早前公布拟斥1,500万美元收购Yooya,惟双方无法就收购事项之主要条款达成议,故收购事项之讨论已终止并於7月17日生效。
公司指在与Yooya讨论时,管理层获得一个令人兴奋、具体及合适的机会进军中国之大麻行业,特别关注大麻二酚(CBD)注入式产品,该等产品在中国将需要大麻种植牌照以及加工及推出大麻加工设施之牌照。董事局相信,此潜在收购事项在创造长期价值方面将对股东非常有利,且对股东之摊薄影响较Yooya交易事项为低。倘及於达成协议时,公司将根据香港上市规则以惯常方式作出公布。~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.